This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  83R17841 BK-D
 
  By: Zerwas H.C.R. No. 98
 
 
 
CONCURRENT RESOLUTION
         WHEREAS, Amyotrophic lateral sclerosis or ALS, better known
  as Lou Gehrig's disease, is a fatal debilitating disease
  characterized by the degeneration of motor nerve cells in the brain
  and spinal cord; and
         WHEREAS, The initial symptom of ALS is often weakness of the
  skeletal muscles, especially those of the extremities; as ALS
  progresses and muscle atrophy worsens, the patient experiences
  difficulty swallowing, talking, and breathing; because ALS does not
  commonly affect mental capacity, sufferers remain alert and aware
  of their loss of motor control and the inevitable outcome of
  continued deterioration; and
         WHEREAS, ALS affects roughly 30,000 Americans, with slightly
  more than 5,600 diagnosed each year; there is no known cause, means
  of prevention, or cure, and on average, patients only survive two to
  five years from the time of diagnosis; and
         WHEREAS, Studies have indicated that military veterans are
  approximately twice as likely to develop ALS as those who have not
  served; in light of this finding, the Department of Veterans
  Affairs implemented a presumption of service connection for ALS,
  thereby concluding that the development of the disease could be
  incurred or aggravated by a person's service in the military; and
         WHEREAS, Through a number of initiatives, researchers are
  investigating possible causes and treatments for ALS, and one
  related endeavor is a national patient registry; administered by
  the Centers for Disease Control and Prevention, the registry is
  currently identifying cases in the United States and may become the
  single largest ALS research project ever undertaken; and
         WHEREAS, During May 2013, health and advocacy organizations
  nationwide are observing Amyotrophic Lateral Sclerosis Awareness
  Month with a variety of activities to raise awareness of the
  profound impact that ALS has on patients, their families, and their
  communities and to recognize and support the important research
  being conducted to end this devastating disease; now, therefore, be
  it
         RESOLVED, That the 83rd Legislature of the State of Texas
  hereby designate May 2013 as Amyotrophic Lateral Sclerosis
  Awareness Month in Texas.